Literature DB >> 29581052

Four-year safety follow-up of the tetravalent dengue vaccine CYD-TDV.

A Wilder-Smith1.   

Abstract

Entities:  

Keywords:  CYD-TDV; Dengue; Safety follow-up; Tetravalent dengue vaccine; Vaccine

Mesh：

Substances：

Year:  2018        PMID： 29581052     DOI： 10.1016/j.cmi.2018.03.024

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  4 in total

Review 1.  Risk of Dengue in Travelers: Implications for Dengue Vaccination.

Authors:  Annelies Wilder-Smith
Journal:  Curr Infect Dis Rep       Date:  2018-10-29       Impact factor: 3.725

Review 2.  Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era?

Authors:  Jedhan Ucat Galula; Gielenny M Salem; Gwong-Jen J Chang; Day-Yu Chao
Journal:  Hum Vaccin Immunother       Date:  2019-08-23       Impact factor: 3.452

3.  Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans.

Authors:  Stefan Malafa; Iris Medits; Judith H Aberle; Stephan W Aberle; Denise Haslwanter; Georgios Tsouchnikas; Silke Wölfel; Kristina L Huber; Elena Percivalle; Pascal Cherpillod; Melissa Thaler; Lena Roßbacher; Michael Kundi; Franz X Heinz; Karin Stiasny
Journal:  PLoS Negl Trop Dis       Date:  2020-02-04

4.  A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.

Authors:  Niraj Mishra; Robbert Boudewijns; Michael Alexander Schmid; Rafael Elias Marques; Sapna Sharma; Johan Neyts; Kai Dallmeier
Journal:  mBio       Date:  2020-04-07       Impact factor: 7.867
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.